HBX

Hana Biosciences (HBX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:HBX
DataOraFonteTitoloSimboloCompagnia
11/04/200613:03Business WireHana Biosciences Obtains NASDAQ National Market Listing Approval; Hana Biosciences Shares to Trade Under Symbol HNAB on the NASAMEX:HBXHana Biosciences
05/04/200613:03Business WireHana Biosciences to Present at the BIO 2006 Business ForumAMEX:HBXHana Biosciences
31/03/200617:03Business WireHana Biosciences to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceutical ConferenceAMEX:HBXHana Biosciences
31/03/200614:03Business WireHana Biosciences Initiates Talotrexin Phase II Clinical Trials in Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)AMEX:HBXHana Biosciences
22/03/200623:23Business WireHana Biosciences to Present at the Bear Stearns' Bear Biotech West Coast ConfabAMEX:HBXHana Biosciences
16/03/200610:03Business WireHana Biosciences Reports 2005 Results from OperationsAMEX:HBXHana Biosciences
09/03/200613:02Business WireHana Biosciences Successfully Completes Pivotal Trials of Zensana(TM), First Proprietary Ondansetron Oral Spray for ChemotherapAMEX:HBXHana Biosciences
06/03/200614:30Business WireHana Biosciences to Present at the Lehman Brothers 9th Annual Global Healthcare ConferenceAMEX:HBXHana Biosciences
02/03/200614:30Business WireHana Biosciences to Present at BioSquare 2006AMEX:HBXHana Biosciences
28/02/200614:30Business WireHana Biosciences to Present at the Cowen & Co. 26th Annual Health Care ConferenceAMEX:HBXHana Biosciences
14/02/200614:30Business WireHana Biosciences Announces Issuance of Talotrexin PatentAMEX:HBXHana Biosciences
07/02/200614:27Business WireHana Biosciences to Present at the 8th Annual BIO CEO & Investor ConferenceAMEX:HBXHana Biosciences
09/01/200614:14Business WireHana Biosciences Announces Positive Results of Initial Registration Trial with Zensana(TM), First Ondansetron Oral Spray for CheAMEX:HBXHana Biosciences
05/01/200612:00Business WireHana Biosciences Announces 2006 Corporate Goals; Key 2005 Achievements Reviewed and 2006 Objectives Announced; Annual ShareholdeAMEX:HBXHana Biosciences
17/11/200518:07Business WireHana Biosciences Announces Positive In Vivo Preclinical Results Confirming Pharmacokinetics of Zensana(TM) (Ondansetron Oral SprAMEX:HBXHana Biosciences
14/11/200513:58Business WireHana Biosciences Announces Positive Interim Results From a Phase I Trial of Talotrexin (PT-523) in Relapsed or Refractory Non-SmAMEX:HBXHana Biosciences
07/11/200514:24Business WireHana Biosciences to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceAMEX:HBXHana Biosciences
26/10/200514:28Business WireHana Biosciences to Present at 3rd Annual PIPES ConferenceAMEX:HBXHana Biosciences
25/10/200514:30Business WireHana Biosciences Completes Previously Announced Private PlacementAMEX:HBXHana Biosciences
24/10/200513:58Business WireHana Biosciences to Present at Life Sciences Conference Hosted by C.E. Unterberg, TowbinAMEX:HBXHana Biosciences
19/10/200521:41Business WireHana Biosciences Announces $14.7 Million Private PlacementAMEX:HBXHana Biosciences
03/10/200515:46Business WireHana Biosciences to Present at BioContact Quebec 2005AMEX:HBXHana Biosciences
22/09/200519:45PR Newswire (US)American Stock Exchange Lists Common Stock of Hana Biosciences IncorporatedAMEX:HBX
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:HBX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network